ProEquip

What ProEquip does

ProEquip (operating from proequip.org) is a pre-launch entity positioning itself in the AI-aware biodefense category. Its stated mission is to ensure civilization can withstand and recover from severe biological crises. The only publicly observable artifact is a "Coming Soon" landing page that frames the offering as protective-equipment-adjacent technology leveraging artificial intelligence for preparedness and response to biological emergencies, alongside a general contact address ([email protected]). No products, services, pricing, distribution model, marketing channels, partnerships, customer segments, geographies, or team members have been disclosed.

No core products or underlying technology have been published. The input contains no patents, no proprietary AI models, no data assets, no integrations, no SDKs, no API surface, no certifications, and no compliance posture. The "AI-aware" framing is a self-description rather than a documented capability, and there is no evidence of in-house research, named talent, or third-party validation. As a result, the technical architecture cannot be characterized beyond the brand promise.

The business model is undefined. Pricing is explicitly unavailable, the company is marked pre-launch with status "Launching Soon," revenue is "Not available," legal entity name and founding date are blank, and there is no disclosed funding, ownership, headcount, or revenue mechanics. Commercial activity is limited to a contact inbox, and there are no known customers, channel partners, or go-to-market motions. The company therefore remains in a stealth/formation stage, with no measurable traction signals in the available data.

Name

ProEquip

Website

https://proequip.org

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

11–50 employees

Short description

ProEquip is a pre-launch company that describes its mission as AI-aware biodefense, aimed at helping civilization withstand and recover from severe biological crises; no products, team, pricing, or customers are publicly disclosed.

Ownership category

akta.pro rank

Product category

Biodefense Protective Equipment

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro industry

PRIMARYHLAJAIAL

Biothreat/Biocontainment & Select Agent Public Health Laboratories

Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Laboratories & Reference Testing Networks

Keywords

• Biodefense equipment
• Protective equipment
• AI biodefense
• Biological crisis response
• Pandemic preparedness

Headquarters

HQ city

Berkeley

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales

Core offering

ProEquip is developing AI-aware biodefense protective equipment designed to help civilization withstand and recover from severe biological crises. The offering combines artificial intelligence with protective gear to support preparedness and emergency response to biological threats. The company is currently in a pre-launch state with a "Coming Soon" website and no shippable products disclosed.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Expansion highlights2 records

Direct peers

• Emergent BioSolutions: Specialty biopharmaceutical company that develops and supplies medical countermeasures (anthrax vaccines, smallpox antivirals, etc.) for biodefense — directly comparable as a biodefense-focused product company serving government stockpiling customers.
• BlueDot: AI-driven infectious disease intelligence and outbreak surveillance platform — directly comparable as an AI-native biodefense/biosurveillance company with overlapping 'AI-aware' technology positioning.
• SIGA Technologies: Commercializes TPOXX, a leading smallpox antiviral stockpiled by governments for biodefense — comparable as a focused biodefense countermeasure developer serving government and public health buyers.
• Ginkgo Bioworks: Synthetic biology platform with an explicit biosecurity/biodefense arm (Concentric by Ginkgo) that uses AI and high-throughput lab infrastructure to detect and respond to biological threats — closely aligned with ProEquip's AI-aware biodefense positioning and mission framing.

Broad incumbents

• 3M: Dominant PPE and respiratory protective equipment manufacturer with deep government, healthcare, and industrial distribution — comparable as the legacy 'protective equipment' incumbent that ProEquip would compete against.
• bioMérieux: Global in vitro diagnostics company whose BioFire division supplies pathogen identification panels used in biothreat response — comparable as a broad incumbent in biodefense diagnostics and surveillance.
• Battelle: Nonprofit applied R&D organization with a dedicated CBRN defense and biodefense business that develops protective equipment and decontamination systems for government clients — comparable as a mission-driven biodefense protective-equipment peer with similar nonprofit DNA.
• Cepheid (Danaher): Molecular diagnostics leader with established biothreat detection test menu (anthrax, smallpox, etc.) used in public health and defense — comparable as a biodefense diagnostic incumbent with broader corporate backing.
• Honeywell: Major manufacturer of respiratory protection, gas masks, and protective equipment used in defense, emergency response, and industrial settings — comparable as a broad PPE and biodefense equipment incumbent.

Emerging players

• Metabiota: Pandemic risk analytics and biosurveillance company focused on infectious disease outbreak modeling for governments and insurers — comparable as an AI/data-driven biodefense startup with overlapping mission and target customers.

Market position

Strengths3 records

Weaknesses3 records

Key risks3 records

Key highlights2 records

Customer concentration

• LinkedInlinkedin.com/company/proequip-bio

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ProEquip